The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia

<p>Abstract</p> <p>Background</p> <p>Establishing preclinical models is essential for novel drug discovery in schizophrenia. Most existing models are characterized by abnormalities in behavioral readouts, which are informative, but do not necessarily translate to the sy...

Full description

Bibliographic Details
Main Authors: Martins-de-Souza Daniel, Alsaif Murtada, Ernst Agnes, Harris Laura W, Aerts Nancy, Lenaerts Ilse, Peeters Pieter J, Amess Bob, Rahmoune Hassan, Bahn Sabine, Guest Paul C
Format: Article
Language:English
Published: BMC 2012-03-01
Series:BMC Research Notes
Subjects:
SRM
MRM
Online Access:http://www.biomedcentral.com/1756-0500/5/146